NeuroVIZR VScan HRV Study
March 13, 2025
Informal Observational Study
This informal observational study explored the effects of NeuroVIZR stimulation on heart rate variability (HRV) and related neurological and autonomic factors.
The study was conducted during February and March 2025 using the VScan HRV System.
NeuroVIZR engaged a professional third-party VScan technician to prepare and conduct the study, with the same technician completing the post-study data review.
Participants
A total of 21 volunteer subjects initially participated in the study.
Three participants were excluded:
- Two due to Light Hypersensitivity;
- One due to an Air Conditioning Reaction.
The final qualified group included 18 participants.
- Age Range: 18–53 years
- Gender: Mixed male and female participants
Measurement Tool
The study used the VScan HRV System to measure heart rate variability and related physiological indicators.
The VScan system is registered as a medical device in Russia and EU countries under the name Dinamika.
Study Objective
The objective was to measure changes in VScan HRV scores before and after a NeuroVIZR session.
Participants completed the Gamma Gamma session from the NeuroVIZR collection.
Study Design
Each participant completed two VScan measurements.
Baseline Measurement
A VScan assessment was performed approximately five minutes before the NeuroVIZR stimulation.
Post-Stimulation Measurement
A second VScan assessment was performed approximately five minutes after the NeuroVIZR stimulation ended.
The results were then reviewed and qualified by the same third-party VScan technician.
Metrics Evaluated
- Peak Performance as measured through Heart Rate Variability (HRV);
- Autonomic nervous system adaptation, including sympathetic and parasympathetic activity;
- Biological Age;
- Generalized Stress measurements.
Summary Findings
Across all qualified subjects following the Gamma Gamma NeuroVIZR session, the study reported the following average changes:
- 14.3% increase in HRV metrics;
- 5.3-year decrease in estimated Biological Age;
- 13.7% decrease in Stress Index.
Conclusion
This informal observational study recorded measurable changes in VScan HRV-related metrics following a single Gamma Gamma NeuroVIZR session.
Among the qualified participants, the reported averages included an increase in HRV metrics, a decrease in estimated Biological Age and a reduction in Stress Index.
These observations provide preliminary data regarding the potential short-term physiological effects associated with NeuroVIZR stimulation.
These findings are based on an informal observational study and should be interpreted as preliminary observations rather than definitive clinical conclusions.